Blogs

Be the first person to recommend this.
11190 Sunrise Valley Drive, Suite 300, Reston, VA 20191 Tel: 703.547.0875 Fax: 703.438.3113 Email: acthq@actox.org Website: www.actox.org Twitter: @ACToxicology
0 comments
Be the first person to recommend this.
The 2021 ACT Abstract Submission System is now open! All abstracts must be submitted online using the online submission system prior to the deadline of June 1, 2021 (11:59 pm, Eastern Time). First-time users will be required to create an account. Once an account confirmation email is received, log into the system and follow the poster guidelines and on-screen prompts to complete your abstract submission. You will receive an email confirmation when you have successfully submitted your abstract. Users may re-enter the system until the deadline to make updates to the abstract or contact information. All accepted poster presenters are required to register ...
0 comments
Be the first person to recommend this.
You are Invited to Participate in a Free Educational Webinar Hot Topics in Clinical Pathology April 28 at 11:30 AM ET Hosted by American College of Toxicology With support from: The British Toxicology Society and the Society of Toxicologic Pathology In collaboration with: Association of Comparative Clinical Pathology Speakers: Brenda Finney, Propath UK Matthew Hartness, Sequani Emilyanne Leonard, AstraZeneca Ian Roman, GlaxoSmithKline Read the full speaker biographies here . This ACT Signature Webinar will cover the following topics: Advances in the Measurement of Thyroid Hormones to Assess Endocrine Disruption Potential ...
0 comments
Be the first person to recommend this.
The ACT mission to “Educate, Lead, and Serve” has been very successful over the years owing in significant part to the generous support of our Corporate Members . In return, these companies benefit by elevating their brand and credibility as an ACT partner. Here are just a few of the many reasons why ACT is so highly regarded in the toxicology community—a reputation that, in turn, affords our Corporate supporters tremendous recognition. In 2020, ACT hosted five signature educational webinars and continued the well-received Basic Training in Toxicology e-Learning Series. We also produced six episodes for the popular ToxChats podcast and held two virtual educational ...
0 comments
Be the first person to recommend this.
Check out the upcoming course co-sponsored by ACT and the Society for Birth Defects Research and Prevention entitled Practical Reproductive and Developmental Toxicology , which will be available for online viewing by registrants by April 15. The course curriculum is both varied and comprehensive, with many well-respected, expert speakers lined up. If you are a regulatory scientist, graduate student, or postdoctoral fellow or are simply interested in learning more about this topic, please view the ACT Educational Courses page for further course details. On-demand viewing for each individual topic will be available to you for 60 days after first accessing ...
0 comments
Be the first person to recommend this.
The ACT Annual Meeting offers a unique, intimate environment unlike any other in the toxicology community. Because of the top-notch scientific programming and well-known, expert speakers who present the latest science, this meeting has earned a reputation among toxicologists worldwide for being the “must attend” event of the year. The size of the meeting is particularly well suited for in-depth peer-to-peer networking, as well as making B2B connections. Annual Meeting Supporters are recognized for their good citizen role in enabling the success of the educational goals of ACT and receive considerable recognition for their generosity via the Annual Meeting Program ...
0 comments
Be the first person to recommend this.
Registration has opened for the 2021 Advanced Comprehensive Toxicology course. The materials for the 2021 course will be available for online viewing by registrants by the July 15, with access available until October 1, 2021! This advanced course is a complement to the Toxicology for Pharmaceutical and Regulatory Scientists course. The virtual lectures will cover detailed descriptions of the principles of toxicology, effects of xenobiotics on organ systems, discussions of specific classes of toxicants, mechanisms of toxicity, risk assessment, and other contemporary toxicological concepts. The content of this course will provide information that may be helpful ...
0 comments
Be the first person to recommend this.
#ACTOX21 #TravelGrant #Fellowship #Graduate #Grant #International #NorthAmerica #Application #Students
0 comments
Be the first person to recommend this.
The 2021 ACT Abstract Submission System is now open! All abstracts must be submitted online using the online submission system prior to the deadline of June 1, 2021 (11:59 pm, Eastern Time). First-time users will be required to create an account. Once an account confirmation email is received, log into the system and follow the poster guidelines and on-screen prompts to complete your abstract submission. You will receive an email confirmation when you have successfully submitted your abstract. Users may re-enter the system until the deadline to make updates to the abstract or contact information. All accepted poster presenters are required to register ...
0 comments
Be the first person to recommend this.
11190 Sunrise Valley Drive, Suite 300, Reston, VA 20191 Tel: 703.547.0875 Fax: 703.438.3113 Email: acthq@actox.org Website: www.actox.org Twitter: @ACToxicology You may view the ACT Privacy Policy, provide consent to ACT to email you communications, or unsubscribe to stop receiving further ACT communication. Privacy Policy | ProvideConsent | Unsubscribe #Virtual #Education #PRDT #Reproductive #eLearning #Developmental #Course #BDRP
0 comments
Be the first person to recommend this.
Having trouble viewing this message? A version is available online . Please forward this announcement to others who you feel may be interested. 11190 Sunrise Valley Drive, Suite 300, Reston, VA 20191 Tel: 703.547.0875 Fax: 703.438.3113 Email: acthq@actox.org Website: www.actox.org Twitter: @ACToxicology You may view the ACT Privacy Policy, provide consent to ACT to email you communications, or unsubscribe to stop receiving further ACT communication. Privacy Policy | Provide Consent | Unsubscribe #Education #eLearning #Inhalation ...
0 comments
Be the first person to recommend this.
In this newly released ToxChats© episode, Dr. Brian McIntosh of Covance describes these cells, how their safety or efficacy are evaluated, explains how these nontraditional precision medicines contribute to the patient’s journey and he shares his thoughts on the future of this type of cancer immunotherapy. (CAR)T cells, also known as chimeric antigen receptor T cells, have transformed the landscape of cancer treatment. Instead of a standard chemotherapy, CAR-T treatment involves taking a patient's blood cells, engineering them in a lab to specifically attack cancer cells, and then injecting them back in the patient. The advent of in silico and in vitro , has ...
0 comments
Be the first person to recommend this.
Drs. Lisa Plitnick and Alan Stokes recently presented an ACT Signature Webinar titled “ History and Risk Assessment of Vaccines: A Practical Perspective from an Immunologist and a Toxicologist .” In this newly released ToxChats© episode, Drs. Lisa Plitnick and Alan Stokes will continue to answer questions from the webinar audience including questions on vaccine development, nonclinical study design, dose selection and extrapolation, and DART requirements. History and Risk Assessment of Vaccines—Q&A Select ToxChats© podcast episodes are available on iTunes and Google Play Music (search ToxChats), in addition, all episodes are on the ACT website. ...
0 comments
Be the first person to recommend this.
Having trouble viewing this message? A version is available online . Please forward this announcement to others who you feel may be interested. 11190 Sunrise Valley Drive, Suite 300, Reston, VA 20191 Tel: 703.547.0875 Fax: 703.438.3113 Email: acthq@actox.org Website: www.actox.org Twitter: @ACToxicology You may view the ACT Privacy Policy, provide consent to ACT to email you communications, or unsubscribe to stop receiving further ACT communication. Privacy Policy | Provide Consent | Unsubscribe
0 comments
Be the first person to recommend this.
Having trouble viewing this message? A version is available online . Please forward this announcement to others who you feel may be interested. 11190 Sunrise Valley Drive, Suite 300, Reston, VA 20191 Tel: 703.547.0875 Fax: 703.438.3113 Email: acthq@actox.org Website: www.actox.org Twitter: @ACToxicology You may view the ACT Privacy Policy, provide consent to ACT to email you communications, or unsubscribe to stop receiving further ACT communication. Privacy Policy | ProvideConsent | Unsubscribe
0 comments
Be the first person to recommend this.
Having trouble viewing this message? A version is available online . Please forward this announcement to others who you feel may be interested. 11190 Sunrise Valley Drive, Suite 300, Reston, VA 20191 Tel: 703.547.0875 Fax: 703.438.3113 Email: acthq@actox.org Website: www.actox.org Twitter: @ACToxicology You may view the ACT Privacy Policy, provide consent to ACT to email you communications, or unsubscribe to stop receiving further ACT communication. Privacy Policy | ProvideConsent | Unsubscribe
0 comments
Be the first person to recommend this.
Having trouble viewing this message? A version is available online . Please forward this announcement to others who you feel may be interested. 11190 Sunrise Valley Drive, Suite 300, Reston, VA 20191 Tel: 703.547.0875 Fax: 703.438.3113 Email: acthq@actox.org Website: www.actox.org Twitter: @ACToxicology You may view the ACT Privacy Policy, provide consent to ACT to email you communications, or unsubscribe to stop receiving further ACT communication. Privacy Policy | ProvideConsent | Unsubscribe
0 comments
Be the first person to recommend this.
Be sure to add these Exhibitor-Hosted Programs to your schedule! Exhibitor-Hosted Programs (Times listed are in Eastern Standard Time) Thursday, November 12, 2020 Test Article Conservation in Nonclinical Inhalation Programs 10:00 AM–10:55 AM Presented by: Covance, Inc. The Minipig as a Model for Juvenile Toxicity Studies 10:00 AM–10:55 AM Presented by: Sinclair Research Center, LLC Challenges to Drug Development in an Evolving International Marketplace: Managing Roadblocks to Success 10:00 AM–10:55 AM Presented by: WuXi AppTec Comparison of US FDA and Health Canada CTA Submission to Support First-in-Human (Healthy ...
0 comments
Be the first person to recommend this.
Having trouble viewing this message? A version is available online . Please forward this announcement to others who you feel may be interested. You are Invited to Participate in a Free Educational Webinar Mechanistic Approaches Using 3D Microtissues to Evaluate Preclinical and Clinical Drug-Induced Liver Injury Wednesday, October 21, 2020 at 11:30 AM ET Hosted by American College of Toxicology Supported by the British Toxicology Society and Society of Toxicologic Pathology Speaker: Professor Armin Wolf, PhD It is estimated that 90% of all compounds entering clinical trials fail, largely due to safety issues ...
0 comments
Be the first person to recommend this.
0 comments